Lucie Sharpsten

1.4k total citations · 1 hit paper
20 papers, 521 citations indexed

About

Lucie Sharpsten is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lucie Sharpsten has authored 20 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 10 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lucie Sharpsten's work include Retinal Imaging and Analysis (8 papers), Glaucoma and retinal disorders (8 papers) and Retinal Diseases and Treatments (7 papers). Lucie Sharpsten is often cited by papers focused on Retinal Imaging and Analysis (8 papers), Glaucoma and retinal disorders (8 papers) and Retinal Diseases and Treatments (7 papers). Lucie Sharpsten collaborates with scholars based in United States, Japan and China. Lucie Sharpsten's co-authors include Felipe A. Medeiros, Robert N. Weinreb, Naira Khachatryan, Naama Hammel, Jeffrey M. Liebmann, Christopher A. Girkin, Pamela A. Sample, Atsuya Miki, Sonia Jain and Feng He and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Ophthalmology.

In The Last Decade

Lucie Sharpsten

16 papers receiving 510 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

2024 115 citations Murielle M. Véniant, Shu-Chen Lu et al. Nature Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lucie Sharpsten United States	10	349	291	86	70	68	20	521
Mohammed Salman India	7	189 0.5×	135 0.5×	25 0.3×	19 0.3×	37 0.5×	25	349
Jianteng Xie China	11	138 0.4×	126 0.4×	17 0.2×	54 0.8×	45 0.7×	22	331
H. Freyler Austria	10	169 0.5×	122 0.4×	60 0.7×	37 0.5×	17 0.3×	77	321
J. R. Vingerling Netherlands	9	783 2.2×	649 2.2×	46 0.5×	51 0.7×	16 0.2×	17	889
David A. Price United States	13	491 1.4×	583 2.0×	39 0.5×	43 0.6×	16 0.2×	22	744
Gavin Tan Singapore	11	315 0.9×	295 1.0×	76 0.9×	25 0.4×	16 0.2×	18	433
Alexander H. Rulo Netherlands	10	423 1.2×	155 0.5×	14 0.2×	40 0.6×	24 0.4×	11	500
Ville Saarela Finland	13	350 1.0×	319 1.1×	30 0.3×	24 0.3×	14 0.2×	44	484
Fatma Yülek Türkiye	10	196 0.6×	138 0.5×	16 0.2×	49 0.7×	20 0.3×	41	334
Stefan Palkovits Austria	16	578 1.7×	442 1.5×	7 0.1×	75 1.1×	28 0.4×	50	704

Countries citing papers authored by Lucie Sharpsten

Since Specialization

Citations

This map shows the geographic impact of Lucie Sharpsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucie Sharpsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucie Sharpsten more than expected).

Fields of papers citing papers by Lucie Sharpsten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucie Sharpsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucie Sharpsten. The network helps show where Lucie Sharpsten may publish in the future.

Co-authorship network of co-authors of Lucie Sharpsten

This figure shows the co-authorship network connecting the top 25 collaborators of Lucie Sharpsten. A scholar is included among the top collaborators of Lucie Sharpsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucie Sharpsten. Lucie Sharpsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Véniant, Murielle M., Shu-Chen Lu, Larissa Atangan, et al.. (2024). A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings. Nature Metabolism. 6(2). 290–303. 115 indexed citations breakdown →

Strande, Jennifer L., Rajneet K. Oberoi, Lucie Sharpsten, et al.. (2023). A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and MultipleAscending Dose Study of AMG 133 in Subjects with Obesity. Metabolism. 142. 155433–155433. 5 indexed citations

Moretz, Chad, et al.. (2019). Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study. SHILAP Revista de lepidopterología.

Moretz, Chad, et al.. (2019). <p>Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study</p>. International Journal of COPD. Volume 14. 1721–1737. 17 indexed citations

An, Jaejin, et al.. (2019). Impact of pill burden on adherence to hepatitis C medication. Current Medical Research and Opinion. 35(11). 1937–1944. 8 indexed citations

Groth, Sylvia L., et al.. (2019). SALT Trial: Steroids after Laser Trabeculoplasty. Ophthalmology. 126(11). 1511–1516. 29 indexed citations

Moretz, Chad, et al.. (2019). <p>Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol</p>. International Journal of COPD. Volume 14. 2047–2060. 9 indexed citations

Buikema, Ami, Lee Brekke, Amy Anderson, et al.. (2018). The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models. Multidisciplinary Respiratory Medicine. 13(1). 38–38. 8 indexed citations

Arcinue, Cheryl A., Dirk‐Uwe Bartsch, Sharif El-Emam, et al.. (2015). Retinal Thickening and Photoreceptor Loss in HIV Eyes without Retinitis. PLoS ONE. 10(8). e0132996–e0132996. 16 indexed citations

10.

Ramkumar, Hema L., William R. Freeman, Giulio Barteselli, et al.. (2015). Visual phenomena perceived during pars plana vitrectomy under peribulbar block and monitored anaesthesia care. British Journal of Ophthalmology. 100(6). 777–781.

11.

Khachatryan, Naira, Felipe A. Medeiros, Lucie Sharpsten, et al.. (2015). The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects. American Journal of Ophthalmology. 159(4). 777–787.e1. 44 indexed citations

12.

Hammel, Naama, Naira Khachatryan, Lucie Sharpsten, et al.. (2015). Diagnostic Accuracy of the Spectralis and Cirrus Reference Databases in Differentiating between Healthy and Early Glaucoma Eyes. Ophthalmology. 123(2). 408–414. 28 indexed citations

13.

Hammel, Naama, Akram Belghith, Christopher Bowd, et al.. (2015). Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes. Ophthalmology. 123(4). 760–770. 12 indexed citations

14.

Zhang, Peng, et al.. (2015). Log‐gamma linear‐mixed effects models for multiple outcomes with application to a longitudinal glaucoma study. Biometrical Journal. 57(5). 766–776. 5 indexed citations

15.

Sharpsten, Lucie, Felipe A. Medeiros, Naira Khachatryan, et al.. (2014). Diagnostic Innovations in Glaucoma Study (DIGS): Diagnostic Accuracy of the Spectralis Normative Database in Differentiating between Healthy and Early Visual Field Defect Eyes. Investigative Ophthalmology & Visual Science. 55(13). 4773–4773.

16.

Sharpsten, Lucie, Juanjuan Fan, Shaban Demirel, et al.. (2014). Predicting progressive glaucomatous optic neuropathy using random forests based on longitudinally collected standard automated perimetry data. Investigative Ophthalmology & Visual Science. 55(13). 5619–5619. 1 indexed citations

17.

Lisboa, Renato, et al.. (2014). Use of Statistical Analyses in the Ophthalmic Literature. Ophthalmology. 121(7). 1317–1321.

18.

Arcinue, Cheryl A., Feiyan Ma, Giulio Barteselli, et al.. (2014). One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration. American Journal of Ophthalmology. 159(3). 426–436.e2. 67 indexed citations

19.

Miki, Atsuya, Felipe A. Medeiros, Robert N. Weinreb, et al.. (2014). Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma Suspect Eyes. Ophthalmology. 121(7). 1350–1358. 156 indexed citations

20.

Sharpsten, Lucie, et al.. (2013). PREDICTING GLAUCOMA PROGRESSION USING DECISION TREES FOR CLUSTERED DATA BY GOODNESS OF SPLIT. International Journal of Semantic Computing. 7(2). 157–172. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact